Abstract | OBJECTIVE: STUDY DESIGN: Eighty-seven patients with ovarian cancer underwent initial debulking surgery and received cisplatin-based chemotherapy after surgery. Immunostaining for GST pi was performed on formalin-fixed sections of the patients' tumors. The cytologic slides of 24 cases were acquired for evaluation of GST pi staining. RESULTS: Of 87 surgically resected specimens, 55 (63.2%) were GST pi positive. Twenty-five of 28 patients (89.3%) who showed no response to chemotherapy had GST pi-positive tumor cells. The predictive value of positive GST pi staining for drug resistance was 75.8% (25/33). Of 18 cases that were GST pi positive in surgically resected specimens, 17 were positive in ascites cytology. Five cases were negative in both resected specimens and ascites cytology. There was a significant correlation in the GST pi labelling index between resected specimen and ascites cytology from the same case; the correlation coefficient was .701 and P value < .001. CONCLUSION: Overexpression of GST pi is related to resistance to cisplatin, and GST pi staining of ascites cytology can be used in pretherapeutic assessment of patients with ovarian cancer.
|
Authors | H Kase, S Kodama, E Nagai, K Tanaka |
Journal | Acta cytologica
(Acta Cytol)
1998 Nov-Dec
Vol. 42
Issue 6
Pg. 1397-402
ISSN: 0001-5547 [Print] Switzerland |
PMID | 9850649
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Glutathione Transferase
- Cisplatin
|
Topics |
- Adult
- Antineoplastic Agents
(administration & dosage)
- Ascites
(enzymology, pathology)
- Cisplatin
(administration & dosage)
- Cystadenocarcinoma
(enzymology, pathology, surgery)
- Drug Resistance, Neoplasm
- Female
- Glutathione Transferase
(analysis, immunology)
- Humans
- Immunohistochemistry
- Middle Aged
- Ovarian Neoplasms
(enzymology, pathology, surgery)
|